404 related articles for article (PubMed ID: 19309721)
1. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
Kaplan MM; Poupon R
Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
[No Abstract] [Full Text] [Related]
2. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
3. [Primary biliary cirrhosis: therapeutic options].
Abenavoli L
Recenti Prog Med; 2009 Sep; 100(9):417-23. PubMed ID: 19886235
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid in primary biliary cirrhosis.
Combes B
Semin Liver Dis; 1997 May; 17(2):125-8. PubMed ID: 9170199
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for primary biliary cirrhosis--convergent thinking.
Altschuler EL
Eur J Gastroenterol Hepatol; 2000 May; 12(5):587. PubMed ID: 10833107
[No Abstract] [Full Text] [Related]
8. Search for medical treatment for primary biliary cirrhosis.
LaRusso N
Lancet; 1997 Oct; 350(9084):1046. PubMed ID: 10213545
[No Abstract] [Full Text] [Related]
9. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
10. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
11. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
Yan G; Erik C; Gluud C
Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
[No Abstract] [Full Text] [Related]
12. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
Mayo MJ
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
[No Abstract] [Full Text] [Related]
13. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
Talwalkar JA; Gossard AA
Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
[No Abstract] [Full Text] [Related]
14. Methotrexate for treatment of primary biliary cirrhosis.
Bonis PA; Kaplan M
Hepatology; 2006 Mar; 43(3):632; author reply 632-3. PubMed ID: 16496314
[No Abstract] [Full Text] [Related]
15. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
Poupon R; Chrétien Y; Chazouillères O; Poupon RE
J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
[No Abstract] [Full Text] [Related]
16. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Makino I
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
[No Abstract] [Full Text] [Related]
17. Primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
[No Abstract] [Full Text] [Related]
18. Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
Kaplan MM; Bonis PA
Gastroenterol Clin Biol; 2010; 34(4-5):239-41. PubMed ID: 20462715
[No Abstract] [Full Text] [Related]
19. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
Benner KG
Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
[No Abstract] [Full Text] [Related]
20. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
